FreeCME

On the Horizon: HER3-Targeted Antibody-Drug Conjugates for Advanced Solid Tumors An Infographic-Enhanced Journal Club Activity Rationale and Mechanism of Action of HER3-Targeted ADCs for Advanced NSCLC and Breast Cancer

CME: 0.25

July 31, 2022
/ Print / Reprints /
| Share More
/ Text Size+

  

Post a comment to this article